+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Inhalers Market by Product Type, Drug Class, Distribution Channel, Indication, Patient Age Group - Global Forecast to 2030- Product Image
Respiratory Inhalers Market by Product Type, Drug Class, Distribution Channel, Indication, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Respiratory Inhalers Market by Product Type, Drug Class, Distribution Channel, Indication, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6012372
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The respiratory inhalers market is transforming rapidly, driven by innovative therapies, evolving regulatory landscapes, and a critical need to address both patient outcomes and operational efficiency. Senior decision-makers in this sector face complex choices as manufacturers, payers, and providers respond to mounting demands for sustainable, patient-centric solutions.

Market Snapshot: Respiratory Inhalers Market

The respiratory inhalers market grew from USD 3.24 billion in 2024 to USD 3.56 billion in 2025. It is expected to continue growing at a CAGR of 9.84%, reaching USD 5.69 billion by 2030. Ongoing technical advances and regulatory shifts are influencing market expansion, as stakeholders seek greater differentiation and resilience across supply chains in the face of changing international dynamics.

Scope & Segmentation

  • Product Types: Dry powder inhalers, metered dose inhalers, nebulizers, and soft mist inhalers are all monitored for adoption across settings and patient demographics.
  • Drug Classes: Analysis includes combination therapies, inhaled corticosteroids, long-acting beta agonists, and short-acting beta agonists, each with distinct roles in respiratory therapy management.
  • Distribution Channels: Evaluation of hospital pharmacies, retail pharmacies, and online channels captures the shifting routes to patient access and therapy initiation.
  • Indications: The report distinguishes between maintenance and rescue uses, clarifying therapeutic priorities and market opportunities.
  • Patient Age Groups: Adult and pediatric segments are analyzed for unique adherence and device requirements.
  • Geographic Regions: Coverage includes Americas (with detailed national breakdown), Europe, Middle East & Africa (highlighting regulatory heterogeneity), and Asia-Pacific (with an emphasis on regional manufacturing and access initiatives).
  • Key Companies Assessed: Profiles and market activities analyzed for leading organizations such as GlaxoSmithKline plc, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novartis AG, Teva Pharmaceutical Industries Ltd., Cipla Ltd., Viatrix Inc., Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Ltd., and Sandoz International GmbH.

Key Takeaways for Decision-Makers

  • Combination inhalers are reshaping therapy protocols as developers integrate multi-pathway treatment into user-friendly devices, improving adherence and outcomes.
  • Manufacturers are responding to heightened environmental scrutiny by phasing in low-global-warming-potential propellants and enhancing device recyclability, which increases appeal among regulators and sustainability-conscious buyers.
  • Digital health integration is enabling real-time monitoring and remote management via embedded sensors, providing value for chronic care pathways and opening new contracting models based on outcomes data.
  • Regional regulation, reimbursement practices, and healthcare infrastructure are strongly influencing product adoption trajectories, making locally customized go-to-market approaches critical for sustained success.
  • Generic competition is intensifying as regulatory hurdles for bioequivalence streamline entry, compelling both innovators and generics to invest in added-value features beyond cost parity alone.

Impact of US Tariffs on Inhaler Supply Chains

New tariffs initiated in 2025 have increased duties on critical inhaler components, affecting cost structures throughout the respiratory inhaler supply chain. Manufacturers are mitigating impacts through supply chain diversification, production relocation, and closer collaboration with regional partners. This environment has accelerated investment in in-house capabilities and vertical integration, reinforcing resilience against future external shocks.

Methodology & Data Sources

This analysis synthesizes both primary and secondary research. Regulatory filings, peer-reviewed studies, and industry reports provide foundational data. In-depth interviews with key opinion leaders, procurement specialists, and patient representatives supplement these findings. Quantitative and qualitative insights are triangulated through robust comparative frameworks to ensure actionable clarity and analytical rigor.

Why This Report Matters

  • Enables senior leaders to benchmark competitor strategies and anticipate the impact of regulatory and trade policy changes on product positioning and margins.
  • Provides tailored recommendations for market access, supply chain risk management, and sustainable innovation in a highly competitive global environment.
  • Supports execution of value-based and patient-centric strategies, leveraging technology and segmented demand drivers to maximize ROI and care outcomes.

Conclusion

The respiratory inhalers market demands nuanced, data-driven strategies as innovation, regulation, and cost dynamics converge. This report offers targeted insights and practical direction for organizations navigating challenges and unlocking opportunity within this dynamic healthcare segment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Respiratory Inhalers Market, by Product Type
8.1. Introduction
8.2. Dry Powder Inhaler
8.3. Metered Dose Inhaler
8.4. Nebulizer
8.5. Soft Mist Inhaler
9. Respiratory Inhalers Market, by Drug Class
9.1. Introduction
9.2. Combination Therapy
9.2.1. ICS/LABA
9.2.2. ICS/LABA/LAMA
9.2.3. ICS/LAMA
9.2.4. LABA/LAMA
9.3. Inhaled Corticosteroid
9.4. Long-Acting Beta Agonist
9.5. Short-Acting Beta Agonist
10. Respiratory Inhalers Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Respiratory Inhalers Market, by Indication
11.1. Introduction
11.2. Maintenance
11.3. Rescue
12. Respiratory Inhalers Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Americas Respiratory Inhalers Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Respiratory Inhalers Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Respiratory Inhalers Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GlaxoSmithKline plc
16.3.2. AstraZeneca plc
16.3.3. Boehringer Ingelheim International GmbH
16.3.4. Novartis AG
16.3.5. Teva Pharmaceutical Industries Ltd.
16.3.6. Cipla Ltd.
16.3.7. Viatrix Inc.
16.3.8. Chiesi Farmaceutici S.p.A.
16.3.9. Sun Pharmaceutical Industries Ltd.
16.3.10. Sandoz International GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RESPIRATORY INHALERS MARKET MULTI-CURRENCY
FIGURE 2. RESPIRATORY INHALERS MARKET MULTI-LANGUAGE
FIGURE 3. RESPIRATORY INHALERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RESPIRATORY INHALERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ICS/LABA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ICS/LABA/LAMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ICS/LAMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY LABA/LAMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY INHALED CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY LONG-ACTING BETA AGONIST, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SHORT-ACTING BETA AGONIST, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESCUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 47. CANADA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 48. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. CANADA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 51. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 54. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 84. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 85. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 88. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 90. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 91. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. ITALY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 102. ITALY RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 103. ITALY RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. ITALY RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. ITALY RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 107. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 108. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 109. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 130. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 142. QATAR RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. QATAR RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. QATAR RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 145. QATAR RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. QATAR RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. QATAR RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 150. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 151. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 168. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 169. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 174. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 175. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 186. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 187. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 190. POLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. POLAND RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. POLAND RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 193. POLAND RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. POLAND RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. POLAND RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 209. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 211. CHINA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 212. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. CHINA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 215. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 217. INDIA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 218. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. INDIA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 221. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 223. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 224. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 245. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 247. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 248. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 250. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY COMBINATION THERAPY, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 281. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 282. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Respiratory Inhalers market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Viatrix Inc.
  • Chiesi Farmaceutici S.p.A.
  • Sun Pharmaceutical Industries Ltd.
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.56 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.69 Billion
Compound Annual Growth Rate9.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Inhalers & Nebulizers Market by Device Type, Therapeutic Class, Distribution Channel, End User, Indication - Global Forecast to 2030 - Product Image

Inhalers & Nebulizers Market by Device Type, Therapeutic Class, Distribution Channel, End User, Indication - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Digital Dose Inhaler Market by Application, Drug Type, End User, Technology, Distribution Channel - Global Forecast to 2030 - Product Image

Digital Dose Inhaler Market by Application, Drug Type, End User, Technology, Distribution Channel - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Respiratory Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Respiratory Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, COPD), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From
Smart Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Smart Inhalers - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Inhaler Market

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD. Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients. The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive. Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.